Neuroblastoma
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Neuroblastoma

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Neuroblastoma Local Doctors?
Elite in Neuroblastoma
Elite in Neuroblastoma

Duke Children's Health Center Hematology/Oncology Clinic

2301 Erwin Rd, 
Durham, NC 
Experience:
41+ years
Languages Spoken:
English

Susan Kreissman is a Pediatrics provider practicing medicine in Durham, North Carolina. She has been practicing medicine for over 41 years. Dr. Kreissman is rated as an Elite provider by MediFind in the treatment of Neuroblastoma. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Hepatoblastoma, Langerhans Cell Histiocytosis, and Bone Marrow Aspiration. Dr. Kreissman is board certified in American Board Of Pediatrics, Pediatric Hematology-Oncology.

Distinguished in Neuroblastoma
Hematology | Oncology
Distinguished in Neuroblastoma
Hematology | Oncology

Atrium Health Levine Children’s Cancer & Blood Disorders, A Facility Of Carolinas Medical Center

1001 Blythe Blvd., Suite 3000, 
Charlotte, NC 
Experience:
25+ years
Languages Spoken:
English, Spanish
Accepting New Patients
Offers Telehealth

Javier Oesterheld is a Hematologist and an Oncologist practicing medicine in Charlotte, North Carolina. He has been practicing medicine for over 25 years. Dr. Oesterheld is rated as a Distinguished provider by MediFind in the treatment of Neuroblastoma. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Ewing Sarcoma, Osteosarcoma, and Bone Marrow Transplant. Dr. Oesterheld is board certified in American Board Of Pediatrics, Pediatric Hematology And Oncology and American Board Of Pediatrics. Dr. Oesterheld is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Distinguished in Neuroblastoma
Pediatrics | Hematology | Oncology
Distinguished in Neuroblastoma
Pediatrics | Hematology | Oncology

Atrium Health Levine Children’s Cancer & Blood Disorders, A Facility Of Carolinas Medical Center

1001 Blythe Blvd., Suite 3000, 
Charlotte, NC 
Experience:
25+ years
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Joel Kaplan is a Hematologist and a Pediatrics provider practicing medicine in Charlotte, North Carolina. He has been practicing medicine for over 25 years. Dr. Kaplan is rated as a Distinguished provider by MediFind in the treatment of Neuroblastoma. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Medulloblastoma, Langerhans Cell Histiocytosis, and Bone Marrow Aspiration. Dr. Kaplan is board certified in American Board Of Pediatrics and American Board Of Pediatrics, Pediatric Hematology And Oncology. Dr. Kaplan is currently accepting new patients.

What are the latest Neuroblastoma Clinical Trials?
A Phase I Study of Vorinostat in Combination With Vincristine, Irinotecan, and Temozolomide in Children, Adolescents, and Young Adults With Relapsed or Refractory Solid Tumors and CNS Malignancies

Summary: Investigators are testing new experimental drug combinations such as the combination of vorinostat, vincristine, irinotecan, and temozolomide in the hopes of finding a drug that may be effective against tumors that have come back or that have not responded to standard therapy. The goals of this study are: * To find the highest safe dose of vorinostat that can be given together with vincristine, ir...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 1/2 Clinical Trial of the Novel Topoisomerase I Inhibitor PEEL-224 as a Single Agent and in Combination With Vincristine and Temozolomide in Children With Refractory, Progressive or Relapsed Solid Tumors

Summary: The phase 1 primary objective is to determine the pediatric recommended phase 2 dose (RP2D) of PEEL-224 as a single agent (phase 1A) and in combination with vincristine and temozolomide (phase 1B). The phase 2 primary objective is to estimate the objective response rate (ORR) in children with refractory, progressive and relapsed NBL and rhabdomyosarcoma (RMS) treated with the RP2D of PEEL-224 in c...